Nephrology
Whole exome sequencing (WES) with in silico gene panel analysis.
Clinical Report (Download a sample report here)
~3-6 weeks*
For detailed information about the sample requirements, please consult our clinical sample requirements page.
Hereditary systemic amyloidosis is an inherited condition where mutated proteins, often transthyretin (TTR), misfold into harmful fibrils that deposit in organs, causing dysfunction and failure. It is an autosomal dominant disease, meaning a single copy of the altered gene from either parent can cause the condition. The most common type is hereditary transthyretin amyloidosis (ATTR), but other hereditary forms involve variants in genes for apolipoproteins A-I (APOA1), A-II (APOA2), C-II (APOC2), fibrinogen (FGA), gelsolin (GSN) and lysozyme (LYZ).
Order a test using our clinical portal
Preview Documents